参考文献

［1］中华医学会呼吸病学分会哮喘学组.上-下气道慢性炎症性疾病联合诊疗与管理专家共识.中华医学杂志，2017（26）：2001-2022.

［2］奥马珠单抗治疗过敏性哮喘专家组，中华医学会呼吸病学分会哮喘学组.奥马珠单抗治疗过敏性哮喘的中国专家共识.中华结核和呼吸杂志，2018，41（3）：179-185.

［3］GIAVINA-BIANCHI P, AUN MV, TAKEJIMA P, et al. United airway disease: current perspectives. J Asthma Allergy, 2016, 9: 93-100.

［4］STOKES J. Anti-IgE Treatment for Disorders Other Than Asthma. Front Med (Lausanne), 2017, 4: 152.

［5］KUPCZYK M, KUNA P. Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives. Drugs, 2017, 77 (12): 1281-1294.

［6］BAYAR MULUK N, BAFAQEEH SA, CINGI C. Anti-IgE treatment in allergic rhinitis. Int J Pediatr Otorhinolaryngol, 2019, 127: 109674.

［7］XIAO L, JIANG L, HU Q, et al. MicroRNA-133b Ameliorates Allergic Inflammation and Symptom in Murine Model of Allergic Rhinitis by Targeting Nlrp3. Cell Physiol Biochem, 2017, 42 (3): 901-912.